OPCH — Option Care Health Inc. stock price and chart

Share this page

OPCH

$31.20-0.06%

as of close, Oct 16, 2026

☾ AH $31.20 -0.06%

Option Care Health Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.008%Russell 3000 0.005%US Stock Market 0.005%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeSEEEE

20162019202120242026

5.010.015.020.025.030.035.0050.0M$31.20

2026-10-16

Price$31.20

MA20$23.23

MA50$27.30

Vol27.9M

What would $1,000 invested in OPCH be worth today? →

OPCH returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $31.20
YTD price return: -2.07%
YTD total return: -2.07%
Next earnings: Oct 29, 2026
Market cap: 4.7B2016-12 489.6M2026-10 4.7B+854.5% over the window
Enterprise value: 5.7B
Shares outstanding: 149.8M2016-06 113.9M2026-06 149.8M+31.5% over the window
52W low: $18.01
52W high: $36.80
From 52W high: -15.22%
From 52W low: +73.24%
52W range: 70%

Volume

Rel volume: 0.51×
30D volume: 5.6M
30D $ vol: 162M

Fundamentals

EPS (ttm): $1.322018-03 -$0.392026-06 $1.32-435.8% over the window
FCF (ttm): 303.8M2017-12 12.9M2026-06 303.8M+2252.7% over the window
FCF/share: $2.032017-12 $0.102026-06 $2.03+1905.9% over the window
Book value/share: $8.412016-06 -$0.162026-06 $8.41-5399.2% over the window
ROE: 16.63%2016-12 -7.1%2026-06 16.6%-333.7% over the window
ROA: 6.20%2016-06 -9.9%2026-06 6.2%-162.6% over the window
Debt / equity: 0.91×2016-12 0.782026-06 0.91+17.5% over the window
Current ratio: 1.472016-06 1.962026-06 1.47-25.2% over the window

Growth (CAGR, ttm) · 10Y

Sales: +13.04%2024-12-31 → 2025-12-315B → 5.6B (+13.0% total)+13.45%2022-12-31 → 2025-12-313.9B → 5.6B (+46.0% total)+13.25%2020-12-31 → 2025-12-313B → 5.6B (+86.3% total)n/a
Net income: -0.79%2025-06-30 → 2026-06-30211.3M → 209.6M (-0.8% total)-4.41%2023-06-30 → 2026-06-30240M → 209.6M (-12.7% total)+34.03%2021-06-30 → 2026-06-3048.5M → 209.6M (+332.5% total)n/a
FCF: +26.01%2025-06-30 → 2026-06-30241.2M → 303.8M (+26.0% total)-4.70%2023-06-30 → 2026-06-30351M → 303.8M (-13.4% total)+16.50%2021-06-30 → 2026-06-30141.6M → 303.8M (+114.5% total)n/a
Shares: -7.72%2025-06-30 → 2026-06-30162.3M → 149.8M (-7.7% total)-5.92%2023-06-30 → 2026-06-30179.9M → 149.8M (-16.7% total)-3.60%2021-06-30 → 2026-06-30179.9M → 149.8M (-16.7% total)+2.78%2016-06-30 → 2026-06-30113.9M → 149.8M (+31.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +5.20%2025-06-30 → 2026-06-30$1.26 → $1.32 (+5.2% total)+0.16%2023-06-30 → 2026-06-30$1.31 → $1.32 (+0.5% total)+37.39%2021-06-30 → 2026-06-30$0.27 → $1.32 (+389.4% total)n/a
Sales/share: +19.45%2024-12-31 → 2025-12-31$30.23 → $36.11 (+19.4% total)+19.30%2022-12-31 → 2025-12-31$21.26 → $36.11 (+69.8% total)+16.45%2020-12-31 → 2025-12-31$16.87 → $36.11 (+114.1% total)n/a
FCF/share: +36.55%2025-06-30 → 2026-06-30$1.49 → $2.03 (+36.5% total)+1.30%2023-06-30 → 2026-06-30$1.95 → $2.03 (+4.0% total)+20.84%2021-06-30 → 2026-06-30$0.79 → $2.03 (+157.7% total)n/a
Book value/share: +0.39%2025-06-30 → 2026-06-30$8.38 → $8.41 (+0.4% total)+0.84%2023-06-30 → 2026-06-30$8.20 → $8.41 (+2.6% total)+7.45%2021-06-30 → 2026-06-30$5.87 → $8.41 (+43.2% total)n/a
Price: +15.14%2025-10-16 → 2026-10-16$27.10 → $31.20 (+15.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.14%2023-10-16 → 2026-10-16$32.29 → $31.20 (-3.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.99%2021-10-15 → 2026-10-16$24.46 → $31.20 (+27.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+9.84%2016-10-14 → 2026-10-16$12.20 → $31.20 (+155.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +15.14%2025-10-16 → 2026-10-16$27.10 → $31.20 (+15.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.14%2023-10-16 → 2026-10-16$32.29 → $31.20 (-3.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+4.99%2021-10-15 → 2026-10-16$24.46 → $31.20 (+27.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.84%2016-10-14 → 2026-10-16$12.20 → $31.20 (+155.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 23.6×2016-12 -10.132026-10 22.30-320.2% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 14.0×2016-12 -1.742026-10 14.00-903.7% over the window
Fwd P/E: 14.9×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.7×2016-12 -20.162026-10 3.71-118.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 15.4×2016-12 -1.452026-10 15.38-1160.5% over the window
EV/EBITDA (fy): 14.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.50%2017-12 0.9%2026-06 9.7%+1011.8% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-03-31) ÷ shares_at(2025-03-31) = 1 − 157.0M ÷ 163.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 4.11%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.11%) + dividends paid over that year ($0) ÷ market_cap_at(2025-03-31) ($5.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.11%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($328.1M) ÷ today's market cap ($4.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 7.02%2016-09 -17.0%2026-06 10.4%-161.4% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $328.1M + TTM dividends $0) ÷ today's market cap ($4.7B). Same caveat as the cash buyback yield.: 7.02%2016-09 -17.0%2026-06 10.4%-161.4% over the window

Vs own 10Y history

P/E: 31st
P/OI: 13th
P/S: 21st
P/B: 61st
P/FCF: 9th

Bar = where today’s multiple sits in OPCH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-0.06%

+0.42%

+27.50%

+41.18%

YTD

-2.07%

+15.13%

+27.56%

Financial statements

Open full OPCH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

OPCH — Option Care Health Inc. price, chart and key statistics